Workflow
子公司增资
icon
Search documents
天津友发钢管集团股份有限公司关于向下属子公司增资暨累计对外投资的公告
登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码:601686 证券简称:友发集团 公告编号:2025-118 转债代码:113058 转债代码:友发转债 天津友发钢管集团股份有限公司 关于向下属子公司增资暨累计对外投资的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏,并对其内容 的真实性、准确性和完整性承担个别及连带责任。 重要内容提示: ● 为提高子公司的资金实力和综合竞争力,优化子公司资产负债结构,推进子公司业务的顺利开展,天 津友发钢管集团股份有限公司(以下简称"公司"或"友发集团")全资子公司天津友发供应链管理有限公 司(以下简称"友发供应链")拟对其全资子公司友发(海南)供应链管理有限公司(以下简称"海南供 应链")增资人民币 30,000 万元,以现金出资方式实缴注册资本。增资完成后,海南供应链的注册资本 由人民币 20,000 万元增加至人民币50,000 万元,仍为友发供应链全资子公司。 (一)对外投资基本情况 公司全资子公司友发供应链拟对其全资子公司海南供应链增资人民币 30,000 万元,以现金出资方式实 缴注册资本。增资完成后,海南供应链 ...
安徽众源新材料股份有限公司 关于2025年10月提供担保的进展公告
Group 1 - The company announced the provision of guarantees for its subsidiaries to support their operational needs, with a total guarantee amount of RMB 9,757,162.34 [2][8] - The guarantees are provided in the form of joint liability guarantees, with no counter-guarantees involved [3][4][5][6][7] - The board of directors approved the guarantee arrangements in meetings held on April 25, 2025, and May 16, 2025 [9] Group 2 - The company has a total external guarantee amount of RMB 1,816,978,000, which accounts for 90.38% of the latest audited net assets, with no overdue guarantees reported [11] - The company has not provided guarantees for its controlling shareholders or related parties [11] Group 3 - The company’s wholly-owned subsidiary, Anhui Zhongyuan Investment Co., Ltd., increased the registered capital of its controlling subsidiary, Harbin Hachuan New Material Technology Co., Ltd., by RMB 36.6 million, raising its registered capital from RMB 20 million to RMB 56.6 million [12]
方盛制药: 方盛制药第六届董事会独立董事专门会议2025年第二次临时会议决议
Zheng Quan Zhi Xing· 2025-06-03 10:17
Core Points - The company held the second temporary meeting of the sixth board of independent directors on May 29, 2025, via remote voting, which was legally valid and complied with relevant regulations [2][3] - The meeting approved a proposal for capital increase and related transactions for its subsidiary, GuangDong Fangsheng R&D Pharmaceutical Co., Ltd. (Fangsheng R&D), aimed at enhancing its funding for drug research and development projects [2][3] - The capital increase is expected to improve the sustainability of R&D investments and mitigate the company's risks associated with new product development, ensuring no harm to minority shareholders [2][3] Summary by Sections - **Meeting Details** - The meeting was convened by independent director Yuan Xiong and attended by all three independent directors, confirming the quorum [2] - The proposal was submitted for review at the fourth temporary meeting of the sixth board [3] - **Proposal Approval** - The proposal received unanimous support with 3 votes in favor, 0 against, and 0 abstentions [3] - Independent directors involved in the voting were Gao Xueming, Du Shouying, and Yuan Xiong [3]
深圳新星受累六氟磷酸锂业务三年亏4.8亿 携手国资对子公司增资2亿提升竞争力
Chang Jiang Shang Bao· 2025-05-09 00:01
Core Viewpoint - Shenzhen New Star (603978.SZ) is enhancing its subsidiary's capital structure by introducing a local state-owned investment fund, aiming to improve competitiveness and operational support for its subsidiary, Luoyang New Star [1][7]. Group 1: Capital Increase and Structure - Luoyang New Star plans to raise 200 million yuan through a capital increase, with the registered capital increasing from 1 billion to 1.184 billion yuan, reducing Shenzhen New Star's ownership from 100% to 84.47% while maintaining control [1][3]. - The investment fund, Gongkong New Star Fund, is established with contributions from Shenzhen New Star and local state-owned assets, with a total subscription of 500 million yuan planned [4]. Group 2: Financial Performance and Commitments - Luoyang New Star achieved revenues of 2.423 billion yuan and a net profit of 6.9914 million yuan in 2024, with a performance commitment of a cumulative net profit of no less than 77 million yuan from 2025 to 2027 [2][6]. - Shenzhen New Star reported revenues of 2.563 billion yuan in 2024, but incurred a net loss of 291 million yuan, marking three consecutive years of losses totaling approximately 480 million yuan [2][9]. Group 3: Business Segments and Challenges - Shenzhen New Star operates in three main segments: aluminum grain refiners, battery aluminum foil materials, and lithium hexafluorophosphate, with Luoyang New Star being crucial for the battery aluminum foil segment [1][7]. - The lithium hexafluorophosphate segment faced significant challenges due to low market prices and increased competition, leading to a loss of 42.3482 million yuan in 2024 [8].